Today: 9 June 2026
Telstra stock price slips after RBA rate hike, with Feb 19 results now in focus
3 February 2026
1 min read

Telstra stock price slips after RBA rate hike, with Feb 19 results now in focus

Sydney, Feb 3, 2026, 17:28 AEDT — Market closed.

  • Telstra shares ended down 0.4% at A$4.89 on Tuesday, bucking a broader market rise.
  • The RBA lifted the cash rate by 25 basis points to 3.85%, shifting the rate backdrop for dividend-heavy stocks.
  • Investors’ next hard catalyst is Telstra’s half-year results and interim dividend decision on Feb. 19.

Telstra Group Limited (ASX:TLS) shares fell 0.4% to close at A$4.89 on Tuesday, after trading between A$4.87 and A$4.95. Volume was about 19.9 million shares, above its recent average, data showed.

The move matters because the Reserve Bank of Australia has just tightened policy again, and Telstra often trades like a yield stock — one that can lose its edge when rates rise. With reporting season approaching, investors are also trying to get positioned ahead of Telstra’s next set of numbers.

Australia’s central bank raised the cash rate target by 25 basis points to 3.85% on Tuesday, its first increase since 2023, after inflation firmed late last year, Reuters reported.

In its statement, the RBA said inflation “picked up materially” in the second half of 2025 and that it was “likely to remain above target for some time,” pointing to capacity pressures and stronger private demand. https://www.rba.gov.au/media-releases/2026…

The rate decision landed on a day when Australian equities finished higher overall. The S&P/ASX 200 rose 0.89% to 8,857.1 points, after giving back some early gains post-decision, according to a market wrap from Commonwealth Bank.

For Telstra investors, the calendar is doing much of the work. The company is scheduled to announce half-year results on Feb. 19, with key dividend dates clustered soon after.

Traders will be listening for any change in tone on pricing and churn in mobile and broadband, and for signs the enterprise business is stabilising. Cost-out progress will be another swing factor, particularly if higher rates keep pressure on consumer budgets.

Competition is the constant backdrop. Telstra faces Singtel-owned Optus and TPG Telecom across mobile and fixed, and discount brands have been aggressive, forcing the big carriers to defend margins without losing subscribers.

Still, the downside case is straightforward: if the RBA’s move turns into a longer tightening cycle, dividend payers can re-rate lower, and any earnings miss or cautious outlook from Telstra could amplify that shift.

Stock Market Today

  • NOV Stock Up 32% in Six Months: Key Factors and Investor Outlook
    June 9, 2026, 10:21 AM EDT. NOV Inc. shares have surged 31.5% over six months, outpacing the Mechanical and Equipment Oil and Gas sub-industry and broader energy sector. The company benefits from strong offshore equipment demand, driven by subsea flexible pipe growth and offshore projects through 2028. NOV's focus on automation and cost reduction, including headcount and facility cuts, supports operational efficiency. Management anticipates a multi-year upcycle in capital equipment spending due to energy security and renewed offshore investment, bolstering demand. With a solid backlog and positive 2026 earnings outlook, NOV's positioning suggests potential for continued gains, raising questions for investors on whether to hold or sell amid market shifts.

Latest articles

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

9 June 2026
IREN surged 8.9% to $59.19 and was quoted higher premarket after a bitcoin rebound and renewed focus on its pivot to AI cloud infrastructure, but the stock remains exposed to bitcoin swings, heavy spending, and risks tied to its new 800MW South Australia data center project and major contracts with Nvidia and Microsoft.
AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

9 June 2026
AT&T shares edged up to $22.58 pre-market after reaffirming 2026 guidance and a $45B+ shareholder return plan, providing a cash-flow marker as satellite broadband competition looms; the stock remains pressured by SpaceX risks flagged by Oppenheimer, with second-quarter free cash flow seen at $4.0–$4.5B.
GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
Nebius (NBIS) stock rebounds after a wild session as Feb. 12 results loom
Previous Story

Nebius (NBIS) stock rebounds after a wild session as Feb. 12 results loom

Legal & General share price rises after Meiji Yasuda deal closes, £1.2bn buyback in focus
Next Story

Legal & General share price rises after Meiji Yasuda deal closes, £1.2bn buyback in focus

Go toTop